Literature DB >> 18360898

Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection.

Rika Yamada1, Toshiyuki Sasagawa, Leah W Kirumbi, Alan Kingoro, Dominic K Karanja, Michael Kiptoo, George W Nakitare, Hiroshi Ichimura, Masaki Inoue.   

Abstract

Human papillomavirus (HPV) infection and cervical abnormalities, and their association with human immunodeficiency virus (HIV) infection were studied in 488 women who visited a health center in Nairobi. PCR-based HPV and cervical cytology tests were carried out on all participants, and peripheral CD4+ T cells and plasma HIV RNA were quantitated in HIV positive women. HIV were positive in 32% (155/488) of the women; 77% of these were untreated, and the others had been treated with anti-retroviral drugs within 6 months. Cervical HPV infection was detected in 17% of HIV negative and 49% of HIV positive women. Low-grade squamous intraepithelial lesions were observed in 6.9% of HIV negative and 21% of HIV positive women, while high-grade squamous intraepithelial lesions and cancer were seen in 0.6% and 5.8%, respectively. Multivariate analysis revealed that HIV and HPV infections were associated with each other. Cervical lesions were significantly associated with high-risk HPVs and with HIV infection, depending on HPV infection. HPV infection increased in accordance with lower CD4+ T cell counts and higher HIV RNA levels, and high-grade lesions were strongly associated with high-risk HPV infection and low CD4+ T cell counts. Immunosuppression as a result of HIV infection appears to be important for malignant progression in the cervix. Nationwide prevention of HIV infection and cervical cancer screening are necessary for the health of women in this area. High-risk HPV infection and low CD4+ T cell counts are the risk factors for cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360898     DOI: 10.1002/jmv.21170

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  30 in total

1.  Human papillomavirus infection induces NF-κB activation in cervical cancer: A comparison with penile cancer.

Authors:  Masachika Senba; Nathan Buziba; Naoki Mori; Shuichi Fujita; Konosuke Morimoto; Akihiro Wada; Kan Toriyama
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

2.  Prevalence and incidence of cervical intra-epithelial neoplasia among female sex workers in Korogocho, Kenya.

Authors:  S K Njagi; N R Mugo; A J Reid; S Satyanarayana; K Tayler-Smith; W Kizito; J Kwatampora; W Waweru; J Kimani; J S Smith
Journal:  Public Health Action       Date:  2013-12-21

3.  Liquid-based urine cytology as a tool for detection of human papillomavirus, Mycoplasma spp., and Ureaplasma spp. in men.

Authors:  Shohei Kawaguchi; Kazuyoshi Shigehara; Toshiyuki Sasagawa; Masayoshi Shimamura; Takao Nakashima; Kazuhiro Sugimoto; Kazufumi Nakashima; Keiichi Furubayashi; Mikio Namiki
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

4.  High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?

Authors:  Julius Atashili; Adaora A Adimora; Peter M Ndumbe; George M Ikomey; Allen C Rinas; Evan Myers; Joseph Eron; Jennifer S Smith; William C Miller
Journal:  Cancer Epidemiol       Date:  2011-11-01       Impact factor: 2.984

5.  Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships.

Authors:  Jason Soh; Anne F Rositch; Laura Koutsky; Brandon L Guthrie; Robert Y Choi; Rose K Bosire; Ann Gatuguta; Jennifer S Smith; James Kiarie; Barbara Lohman-Payne; Carey Farquhar
Journal:  Int J STD AIDS       Date:  2013-09-18       Impact factor: 1.359

6.  Prevalence and correlates of genital warts in Kenyan female sex workers.

Authors:  Barbara E Kavanaugh; Katherine Odem-Davis; Walter Jaoko; Benson Estambale; James N Kiarie; Linnet N Masese; Ruth Deya; Lisa E Manhart; Susan M Graham; Raymond Scott McClelland
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

7.  Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda.

Authors:  Twaha Mutyaba; Florence Mirembe; Sven Sandin; Elisabete Weiderpass
Journal:  Reprod Health       Date:  2010-05-10       Impact factor: 3.223

Review 8.  Human papillomavirus vaccines: where do they fit in HIV-infected individuals?

Authors:  Cynthia Firnhaber; Timothy Wilkin
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

Review 9.  Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.

Authors:  Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Int Rev Immunol       Date:  2009       Impact factor: 5.311

10.  Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy.

Authors:  Martin Luther Koanga Mogtomo; Louise Carole Gouabe Malieugoue; Carolle Djiepgang; Michel Wankam; Andre Moune; Annie Ngono Ngane
Journal:  Infect Agent Cancer       Date:  2009-06-03       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.